When was Metaphore founded?

Metaphore was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Metaphore located?

Metaphore is headquartered in Cambridge, United States.

Who is the current CEO of Metaphore?

Lovisa Afzelius and Angela Hwang s of Metaphore. Lovisa Afzelius has also founded 2 companies.

How many employees does Metaphore have?

As of Sep 30, 2026, the latest employee count at Metaphore is 57.

Is Metaphore a funded company?

Metaphore is a funded company, having raised a total of $50M across 3 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on May 16, 2023.

When was the latest funding round of Metaphore?

Metaphore's latest funding was a $***** Series C round on Aug 05, 2026, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.88B in funding in 2026 to date.

Where does Metaphore rank among its competitors?

Metaphore ranks 1st amongst 93 active competitors, of which 19 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Metaphore, which secured an undisclosed amount in Aug, 2026.

Who are the top competitors of Metaphore?

Metaphore's top competitors include Panakeia, Tahoe Bio and Algorithmic Biologics. Among them, Metaphore secured the most recent funding round in August, 2026.

Metaphore - 2026 Company Profile, Team, Funding & Competitors

Metaphore is a series C company based in Cambridge (United States), founded in 2021 by Lovisa Afzelius and Daniel Acker. It operates as a Provider of machine language and computational platform for drug discovery. Metaphore has raised $50M in funding. The company has 93 active competitors, including 19 funded and 6 that have exited. Its top competitors include companies like Panakeia, Tahoe Bio and Algorithmic Biologics.

Company Details

Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.

Website: www.metaphorebio.com/
Social
Email ID: *****@metaphorebio.com

Key Metrics

Founded Year

2021

Location

Cambridge, United States

Stage

Series C

Total Funding

$50M in 3 rounds

Latest Funding Round

Series C, Aug 05, 2026, $*****

Investors

Flagship Pioneering & 2 more

Ranked

1^st among 93 active competitors

Employee Count

57 as on Sep 30, 2026

Similar Companies

Panakeia & 114 more

View Metaphore's full profile

Metaphore has raised a total funding of $50M over 3 rounds. Its first funding round was on May 16, 2023. Its latest funding round was a Series C round on Aug 05, 2026 for $*****. 1 investor participated in its latest round. Metaphore has 3 institutional investors.

Here is the list of recent funding rounds of Metaphore:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 05, 2026	3126634	Series C	8249094	2780225	8158633	7886196
Apr 06, 2026	9478169	Series C	4320498	1267033	2268312	TOHO HOLDINGS
May 16, 2023	8215560	Series C	5992750	5185590	4004142	Flagship Pioneering

Access funding benchmarks and valuations. Sign up today!

View details of Metaphore's funding rounds and investors

The founders of Metaphore are Lovisa Afzelius and Daniel Acker. Lovisa Afzelius and Angela Hwang are the CEOs of Metaphore.

Here are the details of Metaphore's key team members:

Lovisa Afzelius: Co-Founder & CEO of Metaphore and founder of 3 other companies, Prologue Medicines, Apriori Bio and Elsa.
Contact Info: 1 email address
Daniel Acker: Former Co-Founder of Metaphore.
Contact Info: 1 email address
Angela Hwang: CEO of Metaphore.
Contact Info: 1 email address

View details of Metaphore's Founder profiles and Board Members

Metaphore's employee count trend

Metaphore has 57 employees as of Sep 26. Here is Metaphore's employee count trend over the years:

Uncover Metaphore's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Metaphore include Panakeia, Tahoe Bio and Algorithmic Biologics. Here is the list of Top 10 competitors of Metaphore, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Metaphore 2021, Cambridge (United States), Series C	Provider of machine language and computational platform for drug discovery	$50M	Flagship Pioneering, TOHO HOLDINGS & 1 others	61/100
2nd	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$4.04M	LocalGlobe, Entrepreneurs First & 6 others	58/100
3rd	Tahoe Bio 2022, San Francisco (United States), Series B	Developer of AI models for drug design using single-cell maps.	$30M	Amplify Partners, Wing Venture Capital & 6 others	57/100
4th	Algorithmic Biologics 2021, Bengaluru (India), Seed	Provider of software solutions for molecular diagnostics and discovery	$2.84M	Bharat Innovation Fund, Axilor Ventures & 3 others	48/100
5th	StoneWise 2018, Haidian (China), Series B	Provider of a software solution solution for molecular modeling	$100M	Hillhouse, Linear Venture & 7 others	43/100
6th	Physiomics 2001, Oxford (United Kingdom), Public	Provider of virtual tumour technology based solutions for pre-clinical and clinical development	-	Shackleton Ventures	41/100
7th	QuanMol Tech 2022, Canada, Seed	Provider of AI based solutions in molecular designing	$3M	Plug and Play Tech Center, Hat-Trick Capital ... & 3 others	40/100
8th	Paradigm4 2009, Waltham (United States), Series A	Clinical data management and analytic tools	-	Kepha Partners, Sigma Prime Ventures & 4 others	39/100
9th	Valence Labs 2017, Montreal (Canada), Acquired	AI research engine focusing on advancing drug discovery through computational biology	$8.5M	Air Street Capital, Fifty Years & 17 others	38/100
10th	SilcsBio 2012, Baltimore (United States), Funding Raised	Provides software and services for computer driven drug design	-	NIH, HHS & 1 others	35/100